North America Precision Diagnostics Market Size, Share & Trends Analysis Report By End-use, By Type, By Application (Oncology, Respiratory Diseases, CNS Disorders, Immunology, Skin Diseases, Genetic Diseases, and Others), By Country and Growth Forecast, 2024 - 2031
The North America Precision Diagnostics Market would witness market growth of 17.5% CAGR during the forecast period (2024-2031).
The US market dominated the North America Precision Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $16,362.9 million by 2031. The Canada market is experiencing a CAGR of 19.7% during (2024 - 2031). Additionally, The Mexico market is exhibiting a CAGR of 20.3% during (2024 - 2031).
Precision diagnostics refers to a sophisticated approach in healthcare that involves using advanced technologies and methodologies to diagnose diseases accurately at a molecular or genetic level. This approach identifies specific biomarkers, genetic mutations, or other molecular signatures unique to a patient's condition.
Moreover, Precision diagnostics aims to tailor medical treatments and interventions based on these individual characteristics, thereby optimizing therapeutic outcomes and minimizing potential side effects.
With higher incidences of cancer, there is a growing demand for advanced diagnostic technologies. This includes genetic testing, next-generation sequencing (NGS), and molecular diagnostics to accurately diagnose and subtype different types of cancer prevalent in the Mexican population. According to All.Can, cancer rank as the third leading cause of death in Mexico, with over 195,000 new cases reported in 2020. The most prevalent types included breast (29,929 cases), prostate (26,742 cases), thyroid (11,227 cases), colon (11,191 cases), and cervical cancer (9,439 cases).
Based on End-use, the market is segmented into Clinical Laboratories, Hospitals, and Others. Based on Type, the market is segmented into Genetic Tests, Esoteric Tests, Direct to Consumer Tests, and Others. Based on Application, the market is segmented into Oncology, Respiratory Diseases, CNS Disorders, Immunology, Skin Diseases, Genetic Diseases, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers AG (Siemens AG)
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- BioMerieux S.A.
- Becton, Dickinson and Company
- Qiagen N.V
- Hologic, Inc.
By End-use
- Clinical Laboratories
- Hospitals
- Others
- Genetic Tests
- Esoteric Tests
- Direct to Consumer Tests
- Others
- Oncology
- Respiratory Diseases
- CNS Disorders
- Immunology
- Skin Diseases
- Genetic Diseases
- Others
- US
- Canada
- Mexico
- Rest of North America
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Precision Diagnostics Market, by End-use
- 1.4.2 North America Precision Diagnostics Market, by Type
- 1.4.3 North America Precision Diagnostics Market, by Application
- 1.4.4 North America Precision Diagnostics Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.3 Top Winning Strategies
- 4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2021, Jul – 2024, May) Leading Players
- 4.4 Porter Five Forces Analysis
- Chapter 5. North America Precision Diagnostics Market by End-use
- 5.1 North America Clinical Laboratories Market by Country
- 5.2 North America Hospitals Market by Country
- 5.3 North America Others Market by Country
- Chapter 6. North America Precision Diagnostics Market by Type
- 6.1 North America Genetic Tests Market by Country
- 6.2 North America Esoteric Tests Market by Country
- 6.3 North America Direct to Consumer Tests Market by Country
- 6.4 North America Others Market by Country
- Chapter 7. North America Precision Diagnostics Market by Application
- 7.1 North America Oncology Market by Country
- 7.2 North America Respiratory Diseases Market by Country
- 7.3 North America CNS Disorders Market by Country
- 7.4 North America Immunology Market by Country
- 7.5 North America Skin Diseases Market by Country
- 7.6 North America Genetic Diseases Market by Country
- 7.7 North America Others Market by Country
- Chapter 8. North America Precision Diagnostics Market by Country
- 8.1 US Precision Diagnostics Market
- 8.1.1 US Precision Diagnostics Market by End-use
- 8.1.2 US Precision Diagnostics Market by Type
- 8.1.3 US Precision Diagnostics Market by Application
- 8.2 Canada Precision Diagnostics Market
- 8.2.1 Canada Precision Diagnostics Market by End-use
- 8.2.2 Canada Precision Diagnostics Market by Type
- 8.2.3 Canada Precision Diagnostics Market by Application
- 8.3 Mexico Precision Diagnostics Market
- 8.3.1 Mexico Precision Diagnostics Market by End-use
- 8.3.2 Mexico Precision Diagnostics Market by Type
- 8.3.3 Mexico Precision Diagnostics Market by Application
- 8.4 Rest of North America Precision Diagnostics Market
- 8.4.1 Rest of North America Precision Diagnostics Market by End-use
- 8.4.2 Rest of North America Precision Diagnostics Market by Type
- 8.4.3 Rest of North America Precision Diagnostics Market by Application
- Chapter 9. Company Profiles
- 9.1 Abbott Laboratories
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Acquisition and Mergers:
- 9.1.6 SWOT Analysis
- 9.2 F. Hoffmann-La Roche Ltd.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.2.5.2 Product Launches and Product Expansions:
- 9.2.6 SWOT Analysis
- 9.3 Siemens Healthineers AG (Siemens AG)
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
- 9.3.5.1 Partnerships, Collaborations, and Agreements:
- 9.3.5.2 Product Launches and Product Expansions:
- 9.3.5.3 Acquisition and Mergers:
- 9.3.6 SWOT Analysis
- 9.4 Thermo Fisher Scientific, Inc.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.6 SWOT Analysis
- 9.5 Danaher Corporation
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
- 9.5.6 SWOT Analysis
- 9.6 Agilent Technologies, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Partnerships, Collaborations, and Agreements:
- 9.6.5.2 Product Launches and Product Expansions:
- 9.6.6 SWOT Analysis
- 9.7 BioMerieux S.A.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Partnerships, Collaborations, and Agreements:
- 9.7.5.2 Acquisition and Mergers:
- 9.7.6 SWOT Analysis
- 9.8 Becton, Dickinson, and Company
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expense
- 9.8.5 SWOT Analysis
- 9.9 Qiagen N.V.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expenses
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Partnerships, Collaborations, and Agreements:
- 9.9.5.2 Product Launches and Product Expansions:
- 9.9.6 SWOT Analysis
- 9.10. Hologic, Inc.
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook